| COVID-19 |
1 |
1 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.9 |
| Impairment |
0 |
0.95 |
| Stress |
0 |
0.98 |
| Anxiety Disorder |
0 |
0.2 |
| Psychological Stress |
0 |
0.99 |
| Anxiety |
0 |
0.17 |
| Depression |
0 |
0.17 |
| Otolaryngology |
0 |
0.16 |
| Biologic Therapy |
0 |
0.1 |
| Brain |
0 |
0.09 |
| Cancer |
0 |
0.09 |
| Fatigue |
0 |
0.09 |
| Geriatrics |
0 |
0.09 |
| Memory |
0 |
0.09 |
| Memory Problems |
0 |
0.09 |
| Pandemic |
0 |
0.09 |
| Pain Management |
0 |
0.07 |
| Antigens |
0 |
0.04 |
| Asthma |
0 |
0.04 |
| Cardiovascular Risk Management |
0 |
0.04 |
| Child |
0 |
0.04 |
| Cough |
0 |
0.04 |
| Dyspnea |
0 |
0.04 |
| Fellowship |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Headache |
0 |
0.04 |
| Hypercholesterolemia |
0 |
0.04 |
| Hypertension |
0 |
0.04 |
| Lipids Management |
0 |
0.04 |
| Massachusetts |
0 |
0.04 |
| Mental Illness |
0 |
0.04 |
| Nutrition |
0 |
0.04 |
| Pain |
0 |
0.04 |
| Social Determinants of Health |
0 |
0.04 |
| Socioeconomics |
0 |
0.04 |